Stanford Startup NuMedii Raises $3.5M in Series a to Grow Big Data for Pharma

Stanford startup NuMedii raises .5M in Series A to grow big data for pharma

Filed under: drug treatment programs maryland

NuMedii raised this oversubscribed initial round to further develop its proprietary technology and prepare its first three internal drug development programs for clinical testing. The company was spun out of biomedical informatics researcher Dr. Atul …
Read more on MedCity News

 

First Study of Diazepam Nasal Spray in People with Epilepsy Shows Feasibility

Filed under: drug treatment programs maryland

For people with epilepsy who experience cluster seizures, it is critical that treatment be administered as soon as a cluster is recognized, to prevent additional seizure activity," said Enrique Carrazana, M.D., Acorda's Chief Medical Officer. "Diazepam …
Read more on DailyFinance

 

Cellceutix Signs Material Transfer Agreement for Research of Kevetrin in

Filed under: drug treatment programs maryland

Per the MTA, Cellceutix will provide MD Anderson with Kevetrin, the Company's novel anti-cancer drug candidate, for laboratory research of Kevetrin as a potential new treatment for Lymphoma and Multiple Myeloma. … Employing more than 19,000 people …
Read more on Marketwire (press release)